Zaman M - Search Results

1

Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

Abdel-Aal AB, Zaman M, Fujita Y, Batzloff MR, Good MF, Toth I. Abdel-Aal AB, et al. Among authors: zaman m. J Med Chem. 2010 Nov 25;53(22):8041-6. doi: 10.1021/jm1007787. Epub 2010 Oct 28. J Med Chem. 2010. PMID: 21028828

2

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.

Zaman M, Abdel-Aal AM, Phillipps KSM, Fujita Y, Good MF, Toth I. Zaman M, et al. Vaccine. 2010 Mar 2;28(10):2243-2248. doi: 10.1016/j.vaccine.2009.12.046. Epub 2009 Dec 31. Vaccine. 2010. PMID: 20045502

3

Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.

Zaman M, Simerska P, Toth I. Zaman M, et al. Curr Drug Deliv. 2010 Apr;7(2):118-24. doi: 10.2174/156720110791011846. Curr Drug Deliv. 2010. PMID: 20158484 Review.

4

Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system.

Skwarczynski M, Zaman M, Urbani CN, Lin IC, Jia Z, Batzloff MR, Good MF, Monteiro MJ, Toth I. Skwarczynski M, et al. Among authors: zaman m. Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5742-5. doi: 10.1002/anie.201002221. Angew Chem Int Ed Engl. 2010. PMID: 20818757 No abstract available.

5

Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine.

Zaman M, Skwarczynski M, Malcolm JM, Urbani CN, Jia Z, Batzloff MR, Good MF, Monteiro MJ, Toth I. Zaman M, et al. Nanomedicine. 2011 Apr;7(2):168-73. doi: 10.1016/j.nano.2010.10.002. Epub 2010 Oct 27. Nanomedicine. 2011. PMID: 21034860

6

Simple synthetic toll-like receptor 2 ligands.

Abdel-Aal AB, Al-Isae K, Zaman M, Toth I. Abdel-Aal AB, et al. Among authors: zaman m. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5863-5. doi: 10.1016/j.bmcl.2011.07.102. Epub 2011 Aug 2. Bioorg Med Chem Lett. 2011. PMID: 21855334

7

Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship.

Zaman M, Abdel-Aal AB, Fujita Y, Phillipps KS, Batzloff MR, Good MF, Toth I. Zaman M, et al. PLoS One. 2012;7(1):e30146. doi: 10.1371/journal.pone.0030146. Epub 2012 Jan 12. PLoS One. 2012. PMID: 22253911 Free PMC article.

8

Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.

Abdel-Aal AB, El-Naggar D, Zaman M, Batzloff M, Toth I. Abdel-Aal AB, et al. Among authors: zaman m. J Med Chem. 2012 Aug 9;55(15):6968-74. doi: 10.1021/jm300822g. Epub 2012 Jul 25. J Med Chem. 2012. PMID: 22800462

9

Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.

Zaman M, Abdel-Aal AB, Fujita Y, Ziora ZM, Batzloff MR, Good MF, Toth I. Zaman M, et al. J Med Chem. 2012 Oct 11;55(19):8515-23. doi: 10.1021/jm301074n. Epub 2012 Sep 25. J Med Chem. 2012. PMID: 22974133

10

M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus.

Skwarczynski M, Kamaruzaman KA, Srinivasan S, Zaman M, Lin IC, Batzloff MR, Good MF, Toth I. Skwarczynski M, et al. Among authors: zaman m. Curr Drug Deliv. 2013 Feb;10(1):39-45. doi: 10.2174/1567201811310010007. Curr Drug Deliv. 2013. PMID: 22998043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,320 results

Search Page

Filters